View More

Approval from DINAVISA, Dirección Nacional de Vigilancia Sanitaria Paraguay

CUREXO's artificial joint surgery robot, CUVIS-joint, has received local regulatory approval from DINAVISA, Dirección Nacional de Vigilancia Sanitaria Paraguay. CUREXO's partner in Paraguay is DROGUEPAR S.A, a distributor of pharmaceuticals and medical devices, and this approval is expected to serve as a bridgehead for expanding into the Latin American market.

View More

Participation in the 4th What's New in Robotics Surgery… Hip Surgery Robot Unveiled

• From Knee Replacement to Hip Replacement… Expansion of Orthopedic Surgical Robot Platform • Proven Precision and Safety Based on Over 30,000 Accumulated Surgeries Medical robotics company CUREXO (CEO Jaejun Lee) announced its participation in the 4th Robotic Joint Replacement Surgery Symposium, held on the 31st at Dragon City in Yongsan, Seoul.The symposium, hosted by the Korean Society for Computer Assisted Orthopaedic Surgery (CAOS Korea), consisted of five sessions and 19 lectures by leading experts in orthopedic surgery. It served as a platform to share trends and clinical experiences in robotic joint replacement surgery both domestically and internationally.CUREXO showcased its hip surgery robot, CUVIS-Joint THA, at the event, conducting demonstrations for medical professionals. Sanghoon Lee, Director of CUREXO's Technology Research Center, participated as a presenter in Session 1, where he introduced the company's flagship products, clinical data, and future technology development plans. Director Lee stated, "CUREXO has expanded the application of its robotic platform from knee replacement to now include hip replacement surgery." He emphasized that "CUVIS-Joint has demonstrated its precision and safety with more than 30,000 surgeries performed globally." The CUVIS-Joint THA robot analyzes 3D anatomical data in detail to a personalized surgical plan. During surgery, its real-time tracking and automatic correction features minimize deviations from the surgical plan, allowing for precise implantation of the artificial joint. Currently, CUVIS-Joint is actively being adopted and utilized not only in major general hospitals in Korea but also in medical institutions in India, Malaysia, Indonesia, and other countries.

View More

CUVIS Spine Successfully Performs First Spinal Surgery in Malaysia

• Successful Spinal Surgeries Performed with CUVIS Spine at KPJ Ipoh Specialist Hospital in Malaysia• Following the Joint Surgery Robot CUVIS Joint, Spinal Robot Now Supplied – Expanding Presence in the Malaysian MarketCUREXO, a medical robotics company, announced on the 27th that its spinal surgery robot, CUVIS Spine, was successfully utilized in two spinal surgeries at a local hospital in Malaysia. The surgeries were conducted at KPJ Ipoh Specialist Hospital located in the state of Perak, Malaysia. The hospital had previously adopted CUREXO's joint replacement robot, CUVIS Joint, and with the recent introduction of CUVIS Spine, the company has further solidified its presence within the hospital. CUREXO stated that the spinal surgeries were completed successfully, receiving positive evaluations in terms of both safety and precision. CUVIS Spine, developed with CUREXO's own technology, enables preoperative surgical planning and features a high-precision robotic arm and real-time navigation tools, allowing for faster, more convenient, and more accurate surgeries compared to conventional manual procedures.CUVIS Spine received regulatory approvals from Korea's MFDS in 2019, followed by Europe's CE and the U.S. FDA, and is currently being used in major hospitals both domestically and internationally. It has also been designated as an innovative medical technology and is undergoing evaluation at Severance Hospital and Pusan National University Yangsan Hospital for inclusion in the Korean national health insurance system. A CUREXO representative stated, "The successful application of CUVIS Spine in real surgeries at a Malaysian hospital is highly meaningful. Building on this case, we plan to accelerate the expansion of spinal surgery robots across the Southeast Asian market."

View More

11th Capek Prize Ceremony

CUREXO has been honored with the "Technological Innovation Product Award" at the 11th Capek Prize Ceremony. The Capek Prize is named after Karel Čapek, the Czech science fiction writer who first coined the term "robot." It is jointly organized by the China Association for Mechatronics Technology and Application and the Capek Prize Committee, recognizing outstanding achievements in the robotics field.

View More

JOA 2025

• CUVIS-Joint: Japanese PMDA-Approved Robotic Joint Surgery System Introduced• Expanding Collaboration with Japanese Medical Professionals at JOA 2024 in Tokyo (May 22–25) CUREXO Inc. (KOSDAQ: 060280), a medical robotics company, announced on May 22 that it is participating in the Japanese Orthopaedic Association (JOA) annual meeting being held in Tokyo from May 22 to 25. The JOA meeting is Japan's largest orthopedic academic event, bringing together experts in orthopedic research, treatment, and surgical outcomes, with over 20,000 members in attendance. At the event, CUREXO is showcasing its robotic joint surgery system CUVIS-Joint to local medical professionals through its Japanese partner, KYOCERA. In March, CUREXO received manufacturing and sales approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA), paving the way for official market entry. The company also secured an exclusive sales agreement with the KYOCERA Group for the Japanese market.A CUREXO official stated, "Based on our partnership with KYOCERA, we aim to strengthen collaboration with hospitals and medical professionals in Japan and gradually expand our market share in the Japanese medical robotics industry."

View More

MDSAP Certification

•  Accelerating Global Expansion in the Medical Robotics Market by Enhancing Product Credibility and Regulatory EfficiencyCUREXO, a medical robotics company led by CEO Jae-Jun Lee, announced on the 21st that it has obtained MDSAP (Medical Device Single Audit Program) certification, which integrates regulatory audits for five major countries : the United States, Canada, Japan, Australia, and Brazil.MDSAP allows medical device manufacturers to undergo a single regulatory audit that satisfies the quality management requirements of all five participating countries. This certification significantly streamlines the approval process, as it can replace or reduce the need for individual audits in each country.With the MDSAP certification, CUREXO has not only strengthened the credibility of its product quality but also reduced the time and cost required for obtaining regulatory approvals in each target market. The certification is expected to serve as a critical turning point in the company's efforts to expand strategically into global markets.A CUREXO official stated, "We are continuously expanding regulatory approvals across key global markets. The MDSAP certification will not only support our entry into new export regions but also enhance trust among our international partners."

View More

Approved by INDIA's CDSCO

CUREXO has received regulatory approval for gait rehabilitation robot "MORNINGWALK" from the Central Drugs Standard Control Organisation (CDSCO) of India.CUREXO plans to accelerate its entry into the Indian rehabilitation market through "MORNINGWALK" in collaboration with local partner Abhinav Futuristics Pvt. Ltd.,a provider of sports science and healthcare solutions in India.Thank You.

View More

KIMES 2025

Thank You for Visiting CUREXO at KIMES 2025!The past four days have been incredible! CUREXO had the privilege of meeting so many industry professionals, exchanging valuable insights, and sharing our vision for the future of medical technology.Your curiosity, feedback, and meaningful conversations made KIMES 2025 even more special for us. Every question and discussion inspires us to push the boundaries of innovation and improve our solutions.CUREXO truly appreciates your support and looks forward to continuing this journey together. Thank you. 

View More

Approval from Japan's PMDA

On March 17, CUREXO received approval from Japan's Pharmaceuticals and Medical Devices Agency(PMDA) for the manufacturing and sales of CUVIS-joint, a robotic system for artificial joint surgery. As a result, We will begin sales of the CUVIS-joint in Japan through KYOCERA Global, who holds the exclusive distribution rights in the country.

View More

AAOS 2025

"AAOS 2025 Has Come to a Successful Close—Thank You!"CUREXO's first appearance at American Academy of Orthopaedic Surgeons (AAOS) 2025 under our official banner was a great success!We sincerely appreciate all the surgeons and industry experts who visited our booth and showed great interest in our innovations.It was a meaningful opportunity to introduce our technology and exchange valuable insights.CUREXO Inc. remains committed to delivering cutting-edge solutions and advancing the future of healthcare.Thank you once again, and we look forward to sharing more exciting updates soon!